Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41.

Documenti analoghi

• Sensitivity to a Nonpeptidic Compound (RPR103611) Blocking Human Immunodeficiency Virus Type 1 Env-Mediated Fusion Depends on Sequence and Accessibility of the gp41 Loop Region
  di: Labrosse, Béatrice, et al.
  Pubblicazione: (2000)
• Possible role of the V3 domain of gp120 in resistance to an amphotericin B derivative (MS8209) blocking human immunodeficiency virus entry.
  di: Pleskoff, O, et al.
  Pubblicazione: (1996)
• Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (fusin).
  di: Pleskoff, O, et al.
  Pubblicazione: (1997)
• ADS-J1 Inhibits Human Immunodeficiency Virus Type 1 Entry by Interacting with the gp41 Pocket Region and Blocking Fusion-Active gp41 Core Formation
  di: Wang, Hongtao, et al.
  Pubblicazione: (2009)
• Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion.
  di: Pleskoff, O, et al.
  Pubblicazione: (1995)